Find An Allergist / Immunologist | Pollen Levels | Journal of Allergy and Clinical Immunology | Annual Meeting  
Contact    About AAAAI   

Search   
Professionals
Featured Resources »

Academy CAN!

Allied Health
Articles of Interest


Ask the Expert

Become a Member

Careers in A/I

Job Placement Center

New Research

Pay for Performance (P4P) Webcast



TOPICS
Overview
Allergic bronchopulmonary aspergilllosis (ABPA)
Anaphylaxis - Updated
Asthma
Asthma Diagnosis
Environmental diagnosis
and management
Asthma Treatment:
Immunotherapy
Asthma Treatment:
Preventing Morbidity
- Updated
Asthma Treatment:
Preventing Mortality

- Updated
Asthma Treatment:
Adherence
Occupational Asthma
Conjunctivitis
Cough
Dermatitis
Atopic - Updated
Contact
Drug Allergy - Updated
Food Allergy - Updated
Hypersensitivity Pneumonitis
Insect Hypersensitivity
Occupational Diseases
Primary Immune Deficiency - Updated
Rhinitis/Rhinosinusitis
Rhinitis - Updated
Sinusitis
Urticaria/Angioedema - Updated
How the Allergist/Immunologist Can Help:
Consultation and Referral Guidelines Citing the Evidence

Disease Group: Urticaria/Angioedema
  1. Patients with acute urticaria or angioedema without an obvious or previously defined trigger.
    [Rationale]
  2. Patients with acute urticaria or angioedema due to a presumed food or drug with need for diagnostic confirmation or assistance with avoidance procedures.
    [Rationale]
  3. Patients with chronic urticaria or angioedema, i.e..those with lesions recurring persistently over a period of six weeks or more.
    [Rationale]
  4. Patients who may have urticarial vasculitis or urticaria with systemic disease (vasculidities, connective tissue disease, rarely malignancies):
    a. Lesions last more than 24 hours, leave ecchymotic, purpuric or hyperpigmented residua on/under the skin, or are associated with pain or burning.
    b. Patients who have typical urticaria/angioedema but have signs and symptoms suggestive of systemic illness.
    c. Patients whose symptom control requires regular steroid use.
    [Rationale]
  5. Patients with chronically recurring angioedema without urticaria.
    [Rationale]
  6. Patients with suspected or proven cutaneous or systemic mastocytosis.
    [Rationale]





© 1996-2009 · All Rights Reserved · American Academy of Allergy Asthma & Immunology
Disclaimers and Contact Information · Site Map







After a severe allergic reaction without a known cause, a trigger should be identified if at all possible. An allergist/immunologist is the most appropriate medical professional to perform this evaluation, which may include a detailed history, physical examination, skin testing, in-vitro tests, and challenges when indicated. Future avoidance of the identified triggers should prevent subsequent anaphylactic episodes.
Diagnostic

Indirect outcome (pharmacotherapy)
See food allergy and drug allergy sections.
Diagnostic

Indirect outcome (pharmacotherapy)
Allergists and dermatologists have more expertise in caring for patients with urticaria than other specialists. Chronic urticaria often has an autoimmune pathogenesis. Consultation with an allergist/immunologist would include: reviewing possible etiologic factors (medications, supplements, dietary factors, animal exposures, physical factors), possible skin testing, possible physical challenges recommending changes in ingestants or contactants, and optimal pharmacotherapy. Allergy/immunology specialists are also knowledgeable of the minimal benefit of multiple laboratory tests in urticaria with an otherwise normal examination.
Diagnostic

Indirect outcome (avoidance, pharmacotherapy)
Allergist/immunologist training and expertise should allow appropriate differential diagnosis, determination of the need for biopsy, elimination of a specific inciting agent, and optimal pharmacotherapy1,4,5.
Diagnostic

Indirect outcome (avoidance, pharmacotherapy)
Such patients may have hereditary or acquired angioedema, paraproteinemia or B-cell malignancies. Allergist/immunologist expertise should allow optimal differential diagnosis, determination of the need for hematology/oncology evaluation, and pharmacologic therapy of hereditary or acquired angioedema due to C1 esterase inhibitor deficiency5-7.
Diagnostic

Indirect outcome (pharmacotherapy)
Allergist/immunologists are trained to diagnose and treat this disease5,8,9.
Diagnostic

Indirect outcome (pharmacotherapy)